Dr. Akintomide Apara, MD, PhD

Dr. Apara practices at Eye Surgery Associates in Hollywood, Florida.

Dr. Apara's NPI, 1356720395, was assigned on May 22, 2015. Dr. Apara graduated from University of Miami, Miller School of Medicine in 2015. Dr. Apara holds Florida license ME150234.

Dr. Apara's primary practice is Eye Surgery Associates, at 300 S Park Rd, Hollywood, FL 33021 in Broward County. The practice phone is (954) 925-2740.

Dr. Apara's primary practice is Eye Surgery Associates in Hollywood, Florida. Dr. Apara is also affiliated with Sanford USD Medical Center. The medical group on file is Edith Sanford Breast Center Sioux Falls. Dmand AI also links Dr. Apara to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Apara practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Apara's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Apara is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Apara's licenses on file in 3 states: Florida, Louisiana and California.

Dmand AI lists age-related macular degeneration, cataract, glaucoma, hypertensive retinopathy, inflammation of iris, retinal detachment, retinal occlusion and surgical retina and vitreous procedures among the conditions Dr. Apara treats.

CMS data shows 8,107 Medicare services from Dr. Apara across 12 procedure codes in 2024, for 409 Medicare patients. Medicare paid $581,618 for them. Every service was in an office.

CMS counts 409 Medicare patients who saw Dr. Apara in 2024. The largest group is 65 to 74, with 183 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Apara's median patient age at 70, with 61% women.

In 2024, Dr. Apara wrote 1,224 Medicare Part D claims for 276 patients. 27% of them were for generic drugs. CMS names the drug for 1,154 of them, across 19 drugs with 11 or more claims each, at $1,809,472 in total drug cost. In 2023, CMS named 1,003 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Apara for performance year 2024, reported individually. Dr. Apara accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Apara in 2017. The most frequent topics are Protein Binding. Dr. Apara's most frequent co-authors are Jeffrey Louis Goldberg, MD and Yan Wang, MD.

CMS Open Payments shows 126 general payments to Dr. Apara from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $1,428.

Dr. Apara graduated from University of Miami, Miller School of Medicine in 2015.

Dr. Apara is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.